Elevated basal insulin secretion in type 2 diabetes caused by reduced plasma membrane cholesterol

Molecular Endocrinology

Volumn 30, Issue 10, 2016, Pages 1059-1069

  Nagaraj, Vini ^a   Kazim, Abdulla S ^a   Helgeson, Johan ^a   Lewold, Clemens ^a   Barik, Satadal ^a,c   Buda, Pawel ^a   Reinbothe, Thomas M ^a,d   Wennmalm, Stefan ^b   Zhang, Enming ^a   Renström, Erik ^a  

^a LUND UNIVERSITY   (Sweden)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^c UNIVERSITY OF NORTH BENGAL   (India)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CHOLESTEROL OXIDASE; GLUCOSE; INSULIN; METHYL BETA CYCLODEXTRIN; SYNTAXIN 1A; VOLTAGE GATED CALCIUM CHANNEL; CALCIUM; CALCIUM CHANNEL;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL FUNCTION; CELL MEMBRANE; CELL MEMBRANE DEPOLARIZATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXOCYTOSIS; FEMALE; HUMAN; HUMAN CELL; INSULIN RELEASE; MALE; MEMBRANE DAMAGE; MEMBRANE POTENTIAL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATION; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; MEMBRANE MICRODOMAIN; METABOLISM; OXIDATION REDUCTION REACTION; PANCREAS ISLET; PHYSIOLOGY; WISTAR RAT;

ANIMALS; CALCIUM; CALCIUM CHANNELS; CELL MEMBRANE; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; EXOCYTOSIS; FEMALE; GLUCOSE; INSULIN; ISLETS OF LANGERHANS; MALE; MEMBRANE MICRODOMAINS; OXIDATION-REDUCTION; RATS; RATS, WISTAR;

EID: 84990062867     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2016-1023     Document Type: Article

References (50)

1. Bickel PE. Lipid rafts and insulin signaling. Am J Physiol Endocrinol Metab. 2002;282:E1-E10.
2. Simons K, Ikonen E. Functional rafts in cell membranes. Nature. 1997;387:569-572.
3. Simons K, van Meer G. Lipid sorting in epithelial cells. Biochemistry. 1988;27:6197-6202.
4. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000;1:31-39.
5. Salaun C, James DJ, Chamberlain LH. Lipid rafts and the regulation of exocytosis. Traffic. 2004;5:255-264.
6. Chamberlain LH, Burgoyne RD, Gould GW. SNARE proteins are highly enriched in lipid rafts in PC12 cells: implications for the spatial control of exocytosis. Proc Natl Acad Sci USA. 2001;98:5619-5624.
7. Lang T. SNARE proteins and 'membrane rafts. J Physiol. 2007;585:693-698.
8. Lang T, Bruns D, Wenzel D, et al. SNAREs are concentrated in cholesterol-dependent clusters that define docking and fusion sites for exocytosis. EMBO J. 2001;20:2202-2213.
9. Xia F, Gao X, Kwan E, et al. Disruption of pancreatic β-cell lipid rafts modifies Kv2.1 channel gating and insulin exocytosis. J Biol Chem. 2004;279:24685-24691.
10. Xia F, Leung YM, Gaisano G, et al Targeting of voltage-gated K+ and Ca2+ channels and soluble N-ethylmaleimide-sensitive factor attachment protein receptor proteins to cholesterol-rich lipid rafts in pancreatic α-cells: effects on glucagon stimulus-secretion coupling. Endocrinology. 2007;148:2157-2167.
11. Vikman J, Jimenez-Feltstrom J, Nyman P, Thelin J, Eliasson L. Insulin secretion is highly sensitive to desorption of plasma membrane cholesterol. FASEB J. 2009;23:58-67.
12. Allen JA, Halverson-Tamboli RA, Rasenick MM. Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci. 2007;8:128-140.
13. Ohtani Y, Irie T, Uekama K, Fukunaga K, Pitha J. Differential effects of α-, β- and γ-cyclodextrins on human erythrocytes. Eur J Biochem. 1989;186:17-22.
14. Neufeld EB, Cooney AM, Pitha J, et al. Intracellular trafficking of cholesterol monitored with a cyclodextrin. J Biol Chem. 1996;271:21604-21613.
15. Yancey PG, Rodrigueza WV, Kilsdonk EP, et al. Cellular cholesterol efflux mediated by cyclodextrins. Demonstration of kinetic pools and mechanism of efflux. J Biol Chem. 1996;271:16026-16034.
16. Smart EJ, Anderson RG. Alterations in membrane cholesterol that affect structure and function of caveolae. Methods Enzymol. 2002;353:131-139.
17. Oncul S, Klymchenko AS, Kucherak OA, et al. Liquid ordered phase in cell membranes evidenced by a hydration-sensitive probe: effects of cholesterol depletion and apoptosis. Biochim Biophys Acta. 2010;1798:1436-1443.
18. MacLachlan J, Wotherspoon AT, Ansell RO, Brooks CJ. Cholesterol oxidase: sources, physical properties and analytical applications. J Steroid Biochem Mol Biol. 2000;72:169-195.
19. Lange Y. Tracking cell cholesterol with cholesterol oxidase. J Lipid Res. 1992;33:315-321.
20. Slotte JP, Gronberg L. Oxidation of cholesterol in low density and high density lipoproteins by cholesterol oxidase. J Lipid Res. 1990;31:2235-2242.
21. Harder T, Scheiffele P, Verkade P, Simons K. Lipid domain structure of the plasma membrane revealed by patching of membrane components. J Cell Biol. 1998;141:929-942.
22. Keller P, Simons K. Cholesterol is required for surface transport of influenza virus hemagglutinin. J Cell Biol. 1998;140:1357-1367.
23. Scheiffele P, Roth MG, Simons K. Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain. EMBO J. 1997;16:5501-5508.
24. Lang J. Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion. Eur J Biochem. 1999;259:3-17.
25. Del Prato S, Marchetti P, Bonadonna RC. Phasic insulin release and metabolic regulation in type 2 diabetes. Diabetes. 2002;51(suppl 1):S109-S116.
26. Weyer C, Hanson RL, Tataranni PA, Bogardus C, Pratley RE. A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. Diabetes. 2000;49:2094-2101.
27. Dankner R, Chetrit A, Shanik MH, Raz I, Roth J. Basal-state hyperinsulinemia in healthy normoglycemic adults is predictive of type 2 diabetes over a 24-year follow-up: a preliminary report. Diabetes Care. 2009;32:1464-1466.
28. Borgono CA, Zinman B. Insulins: past, present, and future. Endocrinol Metab Clin North Am. 2012;41:1-24.
29. Gerber SH, Sudhof TC. Molecular determinants of regulated exocytosis. Diabetes. 2002;51(suppl 1):S3-S11.
30. Romanenko VG, Rothblat GH, Levitan I. Modulation of endothelial inward-rectifier K+ current by optical isomers of cholesterol. Biophys J. 2002;83:3211-3222.
31. Buda P, Reinbothe T, Nagaraj V, et al. Eukaryotic translation initiation factor 3 subunit e controls intracellular calcium homeostasis by regulation of cav1.2 surface expression. PLoS One. 2013;8:e64462.
32. Bergstrand J, Ronnlund D, Widengren J, Wennmalm S. Scanning inverse fluorescence correlation spectroscopy. Optics Express. 2014;22:13073-13090.
33. Wennmalm S, Thyberg P, Xu L, Widengren J. Inverse-fluorescence correlation spectroscopy. Anal Chem. 2009;81:9209-9215.
34. Parasassi T, De Stasio G, Ravagnan G, Rusch RM, Gratton E. Quantitation of lipid phases in phospholipid vesicles by the generalized polarization of Laurdan fluorescence. Biophys J. 1991;60:179-189.
35. Yu C, Alterman M, Dobrowsky RT. Ceramide displaces cholesterol from lipid rafts and decreases the association of the cholesterol binding protein caveolin-1. J Lipid Res. 2005;46:1678-1691.
36. Colon-Saez JO, Yakel JL. The α7 nicotinic acetylcholine receptor function in hippocampal neurons is regulated by the lipid composition of the plasma membrane. J Physiol. 2011;589:3163-3174.
37. Jacobo SM, Guerra ML, Hockerman GH. Cav1.2 and Cav1.3 are differentially coupled to glucagon-like peptide-1 potentiation of glucose-stimulated insulin secretion in the pancreatic β-cell line INS-1. J Pharmacol Exp Ther. 2009;331:724-732.
38. Eggeling C, Ringemann C, Medda R, et al. Direct observation of the nanoscale dynamics of membrane lipids in a living cell. Nature. 2009;457(7233):1159-1162.
39. Hao M, Head WS, Gunawardana SC, Hasty AH, Piston DW. Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic β-cell dysfunction. Diabetes. 2007;56:2328-2338.
40. Bogan JS, Xu Y, Hao M. Cholesterol accumulation increases insulin granule size and impairs membrane trafficking. Traffic. 2012;13(11):1466-1480.
41. Nevins AK, Thurmond DC. Caveolin-1 functions as a novel Cdc42 guanine nucleotide dissociation inhibitor in pancreatic β-cells. J Biol Chem. 2006;281:18961-18972.
42. Hoppa MB, Collins S, Ramracheya R, et al. Chronic palmitate exposure inhibits insulin secretion by dissociation of Ca(2+) channels from secretory granules. Cell Metab. 2009;10:455-465.
43. Olofsson CS, Collins S, Bengtsson M, et al. Long-term exposure to glucose and lipids inhibits glucose-induced insulin secretion downstream of granule fusion with plasma membrane. Diabetes. 2007;56:1888-1897.
44. Jaques F, Jousset H, Tomas A, et al. Dual effect of cell-cell contact disruption on cytosolic calcium and insulin secretion. Endocrinology. 2008;149:2494-2505.
45. Lundbaek JA, Birn P, Girshman J, Hansen AJ, Andersen OS. Membrane stiffness and channel function. Biochemistry. 1996;35:3825-3830.
46. Jennings LJ, Xu QW, Firth TA, Nelson MT, Mawe GM. Cholesterol inhibits spontaneous action potentials and calcium currents in guinea pig gallbladder smooth muscle. Am J Physiol. 1999;277:G1017-G1026.
47. Ostenson CG, Gaisano H, Sheu L, Tibell A, Bartfai T. Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients. Diabetes. 2006;55:435-440.
48. Somanath S, Barg S, Marshall C, Silwood CJ, Turner MD. High extracellular glucose inhibits exocytosis through disruption of syntaxin 1A-containing lipid rafts. Biochem Biophys Res Commun. 2009;389:241-246.
49. Sattar S, Preiss N, Murray D, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet. 2010;375:735-742.
50. Simsek S, Schalkwijk CG, Wolffenbuttel BH. Effects of rosuvastatin and atorvastatin on glycaemic control in type 2 diabetes-the CORALL study. Diabet Med. 2012;29:628-631.